A multicenter phase II trial of Decitabine as first-line treatment of older patients with acute myeloid leukemia judged unfit for induction chemotherapy Running head: First-line DAC for older AML patients unfit for induction

mag(2011)

Cited 23|Views23
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined